Trillium Therapeutics
Financial ratios & Valuation

Historical Multiples (2011 – 2020)

2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 TTM Median
Valuation Ratios
Price/Earnings ratio
-2.93-0.52-7.85-8.83-14.58-7.72-6.35-10.40-10.89-26.1037.58-14.58
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/A3.65K10.46K56.89KN/A
Price/Book Value ratio
3.860.400.994.682.504.213.6410.62-2.69K5.5510.062.50
Price/Cash Flow ratio
-4.91-0.42-13.57-15.28-11.74-10.73-10.60-11.24-18.20-68.13-51.24-10.73
Price/Free Cash Flow ratio
-4.91-0.42-13.39-14.93-11.27-9.49-10.42-11.22-17.97-68.13-50.90-9.49
Price/Earnings Growth ratio
-0.080.00-0.090.790.37-0.08-0.290.260.410.45-0.59-0.08
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/A100%100%N/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/A-26198.38%-41523.64%-161183.72%N/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/A-33543.54%-40029.72%151911.62%N/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/A-33566.12%-40098.64%151351.16%N/A
Effective Tax Rate
N/AN/AN/A-2.80%-0.06%10.39%-0.00%-0.01%-0.06%-0.17%0.36%-0.06%
Return on Assets
-114.84%-67.70%-12.22%-45.70%-16.36%-47.63%-47.76%-76.60%-163.82%-19.72%24.52%-16.36%
Return On Equity
-131.72%-76.78%-12.64%-53.00%-17.17%-54.59%-57.38%-102.12%24775%-21.28%24.68%-17.17%
Return on Capital Employed
-132.64%-78.83%-12.51%-53.42%-24.55%-55.54%-51.32%-111.65%-273.45%-21.99%-28.46%-28.46%
Liquidity Ratios
Current Ratio
7.778.4445.737.7925.008.685.743.551.7213.9312.0312.03
Quick Ratio
7.738.2945.607.7925.008.685.743.551.7213.9311.5311.53
Cash ratio
7.617.4244.307.4124.398.531.951.551.0711.564.268.53
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/A962.542.33K12.79KN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.120.110.030.010.000.000.00N/AN/A0.000.080.00
Debt Equity Ratio
0.140.130.030.010.000.000.00N/AN/A0.000.090.00
Long-term Debt to Capitalization
N/AN/A0.000.010.000.000.00N/AN/AN/A0.000.00
Total Debt to Capitalization
N/AN/A0.000.010.000.000.00N/AN/A0.000.000.00
Interest Coverage Ratio
-223.09N/A-107.11-188.80-289.33-515.85-602.88-1.09K-183.53N/AN/A-289.33
Cash Flow to Debt Ratio
N/AN/A-7.26-26.28-67.67-119.90-275.89N/AN/A-82.96-72.99-119.90
Company Equity Multiplier
1.141.131.031.151.041.141.201.33-151.231.071.091.04
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/A-200.87-153.60-1.11KN/A
Free Cash Flow / Operating Cash Flow Ratio
111.011.021.041.121.011.001.0111.001.12
Cash Flow Coverage Ratio
N/AN/A-7.26-26.28-67.67-119.90-275.89N/AN/A-82.96-72.99-119.90
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/A-82.96-153.50N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A